Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | MMP13 | P45452 | 2/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5607969 | 0.82 | NAALAD2 (0.47) | NAALAD2PKMKDM4ETHRBHTT | |
| SCHEMBL13544391 | 0.82 | NAALAD2 (0.47) | NAALAD2PKMKDM4ETHRBHTT | |
| SCHEMBL1231400 | 0.82 | HDAC3 (0.40) | NAALAD2ALDH1A1TSHRSMN1; SMN2KDM4C | |
| SCHEMBL17206980 | 0.79 | PKM (0.36) | NAALAD2PKMKDM4ETHRBHTT | |
| SCHEMBL11304621 | 0.75 | SMN1; SMN2 (0.36) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL20468376 | 0.72 | PIK3CD (0.34) | NAALAD2PKMKDM4ETHRBHTT | |
| SCHEMBL11392975 | 0.72 | HSD17B10 (0.46) | KDM4EALDH1A1TSHRSMN1; SMN2EPHX1 | |
| SCHEMBL8155896 | 0.69 | — | — | |
| SCHEMBL9913289 | 0.69 | KDM4E (0.39) | PKMKDM4ETHRBHTTALDH1A1 | |
| SCHEMBL17961972 | 0.68 | NAALAD2 (0.47) | NAALAD2PKMKDM4ETHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599479-A1 | SUBSTITUTED IMIDAZOTRIAZINES | Bayer HealthCare AG (DE) | 2005-11-30 | — | — | EP | disclosed |
| EP-1521756-A1 | HETERO-CYCLICALY SUBSTITUTED IMIDAZOTRIAZINES | Bayer HealthCare AG (DE) | 2005-04-13 | — | — | EP | disclosed |
| WO-2004005291-A1 | HETERO-CYCLICALY SUBSTITUTED IMIDAZOTRIAZINES | BAYER HEALTHCARE AG (DE) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004005290-A1 | SUBSTITUTED IMIDAZOTRIAZINES | BAYER HEALTHCARE AG (DE) | 2004-01-15 | — | — | WO | disclosed |